{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:36:36Z","timestamp":1791286596108,"version":"4.1.0"},"reference-count":34,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2008,2,27]],"date-time":"2008-02-27T00:00:00Z","timestamp":1204070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>\n<jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>There are two types of familial hyperaldosteronism (FH): FH\u2010I and FH\u2010II. FH\u2010I is caused by a hybrid <jats:italic>CYP11B1\/CYP11B2<\/jats:italic> gene mutation. The genetic cause of FH\u2010II, which is more common, is unknown. Adrenal hyperplasia and adenomas are features. We previously reported linkage of FH\u2010II to a ~5\u00a0Mb region on chromosome 7p22. We subsequently reported finding no causative mutations in the retinoblastoma\u2010associated Kruppel\u2010associated box gene (<jats:italic>RBaK<\/jats:italic>), a candidate at 7p22 involved in tumorigenesis and cell cycle control.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>In the current study we investigated <jats:italic>RBaK <\/jats:italic>regulatory regions and two other candidate genes: postmeiotic segregation increased 2 (<jats:italic>PMS2<\/jats:italic>, involved in DNA mismatch repair and tumour predisposition) and guanine nucleotide\u2010binding protein alpha\u201012 (<jats:italic>GNA12<\/jats:italic>, a transforming oncogene).<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The <jats:italic>GNA12<\/jats:italic> and <jats:italic>PMS2<\/jats:italic> genes were examined in two affected (A1, A2) and two unaffected (U1, U2) subjects from a large 7p22\u2010linked FH\u2010II family (family 1). No mutations were found.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The <jats:italic>RBaK<\/jats:italic> and <jats:italic>PMS2<\/jats:italic> distal promoters were sequenced to \u20132150\u00a0bp from the transcription start site for <jats:italic>RBaK and<\/jats:italic>\u20132800\u00a0bp for <jats:italic>PMS2<\/jats:italic>. Five unreported single nucleotide polymorphisms (SNPs) were found in subjects A1, A2 but not in U1 or U2; A(\u20132031\u00a0bp)T, T(\u20132030\u00a0bp)G, G(\u2013834\u00a0bp)C, C(\u2013821\u00a0bp)G in <jats:italic>RBaK<\/jats:italic> and A(\u2013876\u00a0bp)G in <jats:italic>PMS2<\/jats:italic>. Additional affected and unaffected subjects from family 1 and from two other 7p22\u2010linked FH\u2010II families and 58 unrelated normotensive control subjects were genotyped for these SNPs.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The five novel SNPs were found to be present in a significant proportion of normotensive controls. The four <jats:italic>RBaK<\/jats:italic> promoter SNPs were found to be in linkage disequilibrium in the normal population. The <jats:italic>RBaK<\/jats:italic> promoter (\u2013)2031T\/2030G\/834C\/821T allele was found to be in linkage disequilibrium with the causative mutation in FH\u2010II family 1, but not in families 2 and 3. The <jats:italic>PMS2 <\/jats:italic>promoter (\u2013)876G allele was also found to be linked to affected phenotypes in family 1.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The<jats:italic> RBaK<\/jats:italic> and <jats:italic>PMS2<\/jats:italic> promoter SNPs alter the binding sites for several transcription factors. Although present in the normal population, it is possible that the <jats:italic>RBaK<\/jats:italic> (\u2013)2031T\/2030G\/834C\/821T and <jats:italic>PMS2<\/jats:italic> (\u2013)876G alleles may have functional roles contributing to the FH\u2010II phenotype in family 1.<\/jats:p><\/jats:list-item>\n<\/jats:list>\n<\/jats:p>","DOI":"10.1111\/j.1440-1681.2008.04882.x","type":"journal-article","created":{"date-parts":[[2008,2,28]],"date-time":"2008-02-28T07:40:22Z","timestamp":1204184422000},"page":"380-385","source":"Crossref","is-referenced-by-count":39,"title":["EXAMINATION OF CHROMOSOME 7p22 CANDIDATE GENES <i>RBaK<\/i>, <i>PMS2<\/i> AND <i>GNA12<\/i> IN FAMILIAL HYPERALDOSTERONISM TYPE II"],"prefix":"10.1111","volume":"35","author":[{"given":"YWA","family":"Jeske","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Kelemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Sukor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Willys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Bulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RD","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Stowasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,2,27]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"257","article-title":"The evolution of primary aldosteronism: 1954\u201367","volume":"62","author":"Conn JW","year":"1966","journal-title":"Harvey Lect"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)93225-C"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1994.tb02519.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00045415-199907000-00012"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001013"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.8.2854"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/355262a0"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1995.1225"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1991.tb01446.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(01)00097-8"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(03)00112-7"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.3.1046"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.9.3214"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.37.11.831"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.02155.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000174299.66369.26"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.10.7212"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02674.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.13.2.762"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.19.10764"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.12.8292"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/371075a0"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197704)39:4 <1867::AID-CNCR2820390820>3.0.CO;2-Q"},{"key":"e_1_2_6_25_2","first-page":"865","volume-title":"Textbook of","author":"Gordon RD","year":"1994"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1086\/420796"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1995.9885"},{"key":"e_1_2_6_28_2","unstructured":"Chip\u2010Mapper.CHIP MAPPER \u2013 Multi\u2010genome Analysis of Positions and Patterns of Elements of Regulation. Access.http:\/\/mapper.chip.org\/mapper\/mapper\u2010main."},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(95)03481-L"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00061.2006"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M604019200"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.4161\/cc.5.11.2773"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000258554.87444.91"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ten.0000139006.29471.9e"},{"key":"e_1_2_6_35_2","first-page":"101","volume-title":"Clinical Medicine Series on","author":"Gordon RD","year":"2001"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2008.04882.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2008.04882.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T10:28:32Z","timestamp":1696933712000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2008.04882.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,27]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1111\/j.1440-1681.2008.04882.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2008.04882.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,27]]}}}